Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)

NCT01063660 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukaemia

Interventions

DRUG: Treosulfan

Sponsor

medac GmbH